Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Impact of Early Mobilization on SAH Patients Physiological Parameters

NCT06286683 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2024-03
Last updated
2024-03-08

Condition(s) studied

Subarachnoid Hemorrhage

Investigational drug(s) / intervention(s)

lung ultrasoundTranscranial Dopplernear-infrared spectroscopy (NIRS)clinical examination

lung ultrasound: Used to diagnose and monitor pulmonary aeration in the context of prolonged decubitus disorders (atelectasis) via the lung ultrasound score (LUS).

Transcranial Doppler: Non-invasive, bedside method of measuring cerebral blood flow.

near-infrared spectroscopy (NIRS): Non-invasive, bedside method of cerebral oximetry that requires no advanced expertise.

clinical examination: clinical examination

Study summary

The aim of the study is to evaluate the physiological response to out-of-bed mobilization in patients admitted to the intensive care unit for subarachnoid hemorrhage. More specifically, the aim is to measure the impact on cerebral perfusion, lung aeration, cardiovascular and respiratory parameters.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Age ≥ 18 years * Aneurysmal SAH * Severity score World Federation Neurological Surgeons I to IV * Secured aneurysm * Eligible for their first early mobilization Exclusion Criteria: * Sedated patient * Disturbed alertness, coma * Unsecured aneurysm * Patients under legal protection (guardianship, curatorship, safeguard of justice)

Primary outcome measure(s)

  • Impact on lung aeration — at T0 before initiation of out-of-bed mobilization, and 15 minutes after moving to the chair.
    Lung Ultrasound Score by lung ultrasound, Ranging from 0 (normal lungs) to 36 (worst case scenario).

Trial sites (1)

FacilityCityRegionStatus
Adéla FOUDHAÏLI Paris France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06286683 on ClinicalTrials.gov ↗ ← All trials in France